References
- Barlow L, Westergren K, Holmberg L, Talbäck M. The completeness of the Swedish Cancer Register: A sample survey for year 1998. Acta Oncol 2009;48:27–33.
- Klint A, Engholm G, Storm HH, Tryggvadottir L, Gislum M, Hakulinen T, . Trends in survival of patients diagnosed with cancer of the digestive organs in the Nordic countries 1964–2003 followed up to the end of 2006. Acta Oncol 2010;49:578–607.
- NORDCAN [Internet]. Available from: www.ancr.nu
- Batty GD, Kivimaki M, Morrison D, Huxley R, Smith GD, Clarke R, . Risk factors for pancreatic cancer mortality: Extended follow-up of the Original Whitehall Study. Cancer Epidemiol Biomarkers Prev 2009;18:673–5.
- Maisonneuve P, Lowenfels AB. Epidemiology of pancreatic cancer: An update. Dig Dis 2010;28:645–56.
- Sant M, Allemani C, Santaquilani M, Knijn A, Marchesi F, Capocaccia R. EUROCARE-4. Survival of cancer patients diagnosed in 1995–1999. Results and commentary. Eur J Cancer 2009;45:931–91.
- Fesinmeyer MD, Austin MA, Li CI, De Roos AJ, Bowen DJ. Differences in survival by histologic type of pancreatic cancer. Cancer Epidemiol Biomarkers Prev 2005;14:1766–73.
- Cress RD, Yin D, Clarke L, Bold R, Holly EA. Survival among patients with adenocarcinoma of the pancreas: A population-based study (United States). Cancer Causes Control 2006;17:403–9.
- Mitry E, Rachet B, Quinn MJ, Cooper N, Coleman MP. Survival from cancer of the pancreas in England and Wales up to 2001. Br J Cancer 2008;99(Suppl 1):S21–3.
- Söreide K, Aagnes B, Moller B, Westgaard A, Bray F. Epidemiology of pancreatic cancer in Norway: Trends in incidence, basis of diagnosis and survival 1965–2007. Scand J Gastroenterol 2010;45:82–92.
- Ferrone CR, Brennan MF, Gonen M, Coit DG, Fong Y, Chung S, . Pancreatic adenocarcinoma: The actual 5-year survivors. J Gastrointest Surg 2008;12:701–6.
- Garcea G, Dennison AR, Pattenden CJ, Neal CP, Sutton CD, Berry DP. Survival following curative resection for pancreatic ductal adenocarcinoma. A systematic review of the literature. JOP 2008;9:99–132.
- Schnelldorfer T, Ware AL, Sarr MG, Smyrk TC, Zhang L, Qin R, . Long-term survival after pancreatoduodenectomy for pancreatic adenocarcinoma: Is cure possible? Ann Surg 2008;247:456–62.
- Connolly MM, Dawson PJ, Michelassi F, Moossa AR, Lowenstein F. Survival in 1001 patients with carcinoma of the pancreas. Ann Surg 1987;206:366–73.
- Cleary SP, Gryfe R, Guindi M, Greig P, Smith L, Mackenzie R, . Prognostic factors in resected pancreatic adenocarcinoma: Analysis of actual 5-year survivors. J Am Coll Surg 2004;198:722–31.
- Gudjonsson B. Pancreatic cancer: Survival, errors and evidence. Eur J Gastroenterol Hepatol 2009;21:1379–82.
- Carpelan-Holmström M, Nordling S, Pukkala E, Sankila R, Lüttges J, Klöppel G, . Does anyone survive pancreatic ductal adenocarcinoma? A nationwide study re-evaluating the data of the Finnish Cancer Registry. Gut 2005;54:385–7.
- Jörgensen MT, Fenger C, Klöppel G, Lüttges J. Long-term survivors among Danish patients after resection for ductal adenocarcinoma of the pancreas. Scand J Gastroenterol 2008;43:581–3.
- The National Patient Register 2009 [Internet]. Available from: http://www.socialstyrelsen.se/register/halsodataregister/patientregistret/inenglish
- The Cause of Death Register 2009 [Internet]. Available from: http://www.socialstyrelsen.se/register/dodsorsaksregistret/bortfallochkvalitet.
- Classification of Surgical procedures (in Swedish). Stockholm: The National Board of Health and Welfare; 1989.
- Classification of Surgical Procedures. Stockholm: The National Board of Health and Welfare; 1997.
- Stata. Stata Statistical Software. Release 9. College Station, TX, USA ed 2005.
- Cancer Incidence in Sweden 2008 [Internet]. Available from: http://www.socialstyrelsen.se/Lists/Artikelkatalog/Attachments/17841/2009-12-1.pdf.
- Nagenthiraja K, Ewertz M, Engholm G, Storm HH. Incidence and mortality of pancreatic cancer in the Nordic countries 1971–2000. Acta Oncol 2007;46:1064–9.
- Baastrup R, Sorensen M, Hansen J, Hansen RD, Würtzen H, Winther JF. Social inequality and incidence of and survival from cancers of the oesophagus, stomach and pancreas in a population-based study in Denmark, 1994–2003. Eur J Cancer 2008;44:1962–77.
- Boeck S, Ankerst DP, Heinemann V. The role of adjuvant chemotherapy for patients with resected pancreatic cancer: Systematic review of randomized controlled trials and meta-analysis. Oncology 2007;72:314–21.
- Stocken DD, Büchler MW, Dervenis C, Bassi C, Jeekel H, Klinkenbijl JH, . Meta-analysis of randomised adjuvant therapy trials for pancreatic cancer. Br J Cancer 2005;92: 1372–81.
- Yip D, Karapetis C, Strickland A, Steer CB, Goldstein D. Chemotherapy and radiotherapy for inoperable advanced pancreatic cancer. Cochrane Database Syst Rev (online). 2006;3:CD002093.
- Sohn TA, Yeo CJ, Cameron JL, Koniaris L, Kaushal S, Abrams RA, . Resected adenocarcinoma of the pancreas-616 patients: Results, outcomes, and prognostic indicators. J Gastrointest Surg 2000;4:567–79.
- Winter JM, Cameron JL, Campbell KA, Arnold MA, Chang DC, Coleman J, . 1423 pancreaticoduodenectomies for pancreatic cancer: A single-institution experience. J Gastrointest Surg 2006;10:1199–210; discussion 210–1.